Trastuzumab combined with ramucirumab and paclitaxel in patients with previously treated human epidermal growth factor receptor 2–positive advanced gastric or gastroesophageal junction cancer
J. Clin. Oncol., Published online June 26, 2023 | DOI: 10.1200/JCO.22.02122